PCN127 What Is the IMPACT of the Introduction of Ipilimumab, Pembrolizumab, and Nivolumab on Malignant Melanoma in Nordics?
Jun 1, 2021, 00:00 AM
10.1016/j.jval.2021.04.219
https://www.valueinhealthjournal.com/article/S1098-3015(21)00436-8/fulltext
Section Title :
Section Order :
10790
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)00436-8&doi=10.1016/j.jval.2021.04.219